Award Recognizes Company’s Vaccine Expertise, Spanning End-to-End Clinical and Commercial Solutions
MORRISVILLE, N.C. – April 22, 2019 – Syneos Health™ (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced it has been named the Best Contract Research Organization (CRO) at the Vaccine Industry Excellence (ViE) Awards. Presented at the World Vaccine Congress in Washington, D.C., the awards recognize the efforts and achievements of companies and individuals in the vaccine industry during the previous year.
“We are honored to be selected by biopharmaceutical companies and industry experts for this prestigious award, recognizing the strength of our end-to-end vaccine solutions,” said Paul Colvin, President, Syneos Health Clinical Solutions. “It’s reflective of both our employee and innovation efforts – from the creation of a high-quality Catalyst Vaccine Network to the development of proprietary data monitoring and eCRF (electronic case form) standards – that are delivering superior value for our customers.”
Syneos Health’s global vaccine expertise spans the clinical and commercial continuum, fueling the development or commercialization of six vaccines approved by the FDA in a recent five-year period. The Company accelerates vaccine study-start up timelines through the Syneos Health Catalyst Vaccine Network, an integrated team of hand-picked, high-performing sites, Institutional Review Boards (IRB) and key solutions partners. Leveraging the Catalyst Vaccine Network, Syneos Health can deliver vaccine studies for US-based vaccine trials more quickly and predictably, enabling database live and sites activated within 30 days.
The ViE Best CRO award winner is selected by industry leaders who vote online for their preferred provider. The finalists are then evaluated by a judging panel on criteria including range of services provided in niche and core therapeutic areas, attention to and quality of relationships with customers and methods of performance improvement.
The ViE recognition comes on the heels of Syneos Health winning the inaugural Association for Clinical Research Professionals (ACRP) All-Stars Award for Sponsors and CROs.
About Syneos Health
Syneos Health (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Created through the merger of two industry leading companies – INC Research and inVentiv Health – we bring together approximately 24,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. To learn more about how we are shortening the distance from lab to life® visit syneoshealth.com or subscribe to our podcast.
Investor Relations Contact:
Senior Vice President, Investor Relations
+1 919 745 2745
Executive Director, External Communications
+1 202 210 5992